The Clinicopathological and Molecular Associations of PD-L1 Expression in Non-small Cell Lung Cancer: Analysis of a Series of 10,005 Cases Tested with the 22C3 Assay
Matthew Evans, Brendan O’Sullivan, Frances Hughes, Tina Mullis, Matthew Ryan Smith, Nicola Trim, Philippe Tanière
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.1007/s12253-018-0469-6 ↗
- Volume · Issue · Pages
- 26 · 1 · 79-89
- Publisher
- Frontiers Media S.A.
- Article URL
- https://doi.org/10.1007/s12253-018-0469-6 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
17 Sep 2018
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 17 Sep 2018 | OpenAlex |
Keywords (as given): PD-L1 expression; non-small cell lung cancer; tumor proportion score; pembrolizumab; EGFR mutation; ALK rearrangement; KRAS mutation; metastatic sites
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- Pathology and Oncology Research
- Publication date used
- 17 Sep 2018 (OpenAlex publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.